Circulating levels of lncRNA-CASC2 were found to be significantly decreased in COPD patients compared to smoking control subjects and were able to distinguish severe COPD from mild and moderate cases [33]. The gene discussed is CASC2; the disease is chronic obstructive pulmonary disease.